Stem cell mobilization characteristics for transplant eligible patients with newly diagnosed multiple myeloma (NDMM) treated with carfilzomib, lenalidomide, dexamethasone, and daratumumab (KRd-Dara) Meeting Abstract
| Authors: | Bhutani, M.; Robinson, M.; Atrash, S.; Watts, N.; Paul, B.; Chhabra, S.; Korde, N.; Begic, X.; Foureau, D. M.; Chung, D. J.; Pineda-Roman, M.; Koya, B.; Varga, C.; Ai, J.; Daniels, N.; Norek, S.; Sutton, S. A.; Anderson, M. B.; Jewell, A. N.; Eldridge, P. W.; Acampora, D.; Symanowski, J. T.; Costa, L. J.; Usmani, S.; Voorhees, P. M. |
| Abstract Title: | Stem cell mobilization characteristics for transplant eligible patients with newly diagnosed multiple myeloma (NDMM) treated with carfilzomib, lenalidomide, dexamethasone, and daratumumab (KRd-Dara) |
| Meeting Title: | 64th Annual Meeting of the American Society of Hematology (ASH) |
| Journal Title: | Blood |
| Volume: | 140 |
| Issue: | Suppl. 1 |
| Meeting Dates: | 2022 Dec 10-13 |
| Meeting Location: | New Orleans, LA |
| ISSN: | 0006-4971 |
| Publisher: | American Society of Hematology |
| Date Published: | 2022-11-15 |
| Start Page: | 4393 |
| End Page: | 4395 |
| Language: | English |
| ACCESSION: | WOS:000893223204181 |
| DOI: | 10.1182/blood-2022-160071 |
| PROVIDER: | wos |
| Notes: | Meeting Abstract -- Source: Wos |
Altmetric
Citation Impact
BMJ Impact Analytics
